← FDA DRUG APPROVALS

FDA ANDA · ANDA090931

TAMSULOSIN HYDROCHLORIDE

Sponsor: SUN PHARM INDS LTD

APPLICATION
ANDA090931
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-15
LATEST ACTION
2019-09-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TAMSULOSIN HYDROCHLORIDEDiscontinued
TAMSULOSIN HYDROCHLORIDE 0.4MG · CAPSULE · ORAL

Approval history

2019-09-09Labeling · Supplement 10 · standardAP
2015-11-09Labeling · Supplement 3 · standardAP
2015-11-09Labeling · Supplement 6 · standardAP
2015-11-09Labeling · Supplement 4 · standardAP
2012-10-12Labeling · Supplement 1 · standardAP
2010-07-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →